User profiles for "author:Julie De Backer"

Julie De Backer

Verified email at ugent.be
Cited by 26479

FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders

LY Sakai, DR Keene, M Renard, J De Backer - Gene, 2016 - Elsevier
FBN1 encodes the gene for fibrillin-1, a structural macromolecule that polymerizes into
microfibrils. Fibrillin microfibrils are morphologically distinctive fibrils, present in all …

Diagnosis, natural history, and management in vascular Ehlers–Danlos syndrome

PH Byers, J Belmont, J Black… - American Journal of …, 2017 - Wiley Online Library
Vascular Ehlers Danlos syndrome (vEDS) is an uncommon genetic disorders characterized
by arterial aneurysm, dissection and rupture, bowel rupture, and rupture of the gravid uterus …

Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome

Y Von Kodolitsch, J De Backer, H Schüler… - The Application of …, 2015 - Taylor & Francis
Three international nosologies have been proposed for the diagnosis of Marfan syndrome
(MFS): the Berlin nosology in 1988; the Ghent nosology in 1996 (Ghent-1); and the revised …

2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European …

H Baumgartner, J De Backer… - European heart …, 2021 - academic.oup.com
Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

BL Loeys, J Chen, ER Neptune, DP Judge… - Nature …, 2005 - nature.com
We report heterozygous mutations in the genes encoding either type I or type II transforming
growth factor β receptor in ten families with a newly described human phenotype that …

[HTML][HTML] Aneurysm syndromes caused by mutations in the TGF-β receptor

BL Loeys, U Schwarze, T Holm… - … England Journal of …, 2006 - Mass Medical Soc
Background The Loeys–Dietz syndrome is a recently described autosomal dominant aortic-
aneurysm syndrome with widespread systemic involvement. The disease is characterized by …

The revised Ghent nosology for the Marfan syndrome

BL Loeys, HC Dietz, AC Braverman… - Journal of medical …, 2010 - jmg.bmj.com
The diagnosis of Marfan syndrome (MFS) relies on defined clinical criteria (Ghent nosology),
outlined by international expert opinion to facilitate accurate recognition of this genetic …

The 2017 international classification of the Ehlers–Danlos syndromes

F Malfait, C Francomano, P Byers… - American Journal of …, 2017 - Wiley Online Library
The Ehlers–Danlos syndromes (EDS) are a clinically and genetically heterogeneous group
of heritable connective tissue disorders (HCTDs) characterized by joint hypermobility, skin …

[PDF][PDF] Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international …

L Faivre, G Collod-Beroud, BL Loeys, A Child… - The American Journal of …, 2007 - cell.com
Mutations in the fibrillin-1 (FBN1) gene cause Marfan syndrome (MFS) and have been
associated with a wide range of overlapping phenotypes. Clinical care is complicated by …

[HTML][HTML] Atenolol versus losartan in children and young adults with Marfan's syndrome

RV Lacro, HC Dietz, LA Sleeper… - … England Journal of …, 2014 - Mass Medical Soc
Background Aortic-root dissection is the leading cause of death in Marfan's syndrome.
Studies suggest that with regard to slowing aortic-root enlargement, losartan may be more …